Somatostatin, Clearance and Inhibition of Gastric Acid Secretion in Duodenal Ulcer Patients
Somatostatin is one of several gastrointestinal peptides of potential physiological significance in the inhibitory regulation of gastric acid secretion. It is produced and released in the gastric mucosa and exogenous administration of this peptide strongly inhibits acid secretion stimulated by a variety of secretagogues in man (1).
KeywordsAcid Secretion Gastric Acid Secretion Acid Output Ulcer Patient Duodenal Ulcer Patient
Unable to display preview. Download preview PDF.
- 2.Konturek SJ, Swierczek J, Kwiecieu N, et al. Effect of somatostatin on meal-induced gastric secretion in duodenal ulcer patients. Dig Dis Sci 1977; 11: 981–8.Google Scholar
- 4.Seal A, Yamada T, Debas H, et al. Somatostatin 14 and 28: clearance and potency on gastric function in dogs. Am J Physiol 1982; 243: G97102.Google Scholar
- 5.Walsh JH. Radioimmunoassay of gastrin. In: Rothfield B, ed. Nuclear medicine in vitro. Philadelphia: Lippincott, 1974: 231–48.Google Scholar